The recent approval of several swine flu vaccines by top pharmaceutical companies will benefit industries associated with the swine flu virus.

Top pharmaceutical companies in conjunction with wealthy nations are to help prevent the spread of the swine flu virus in under developed nations.

Top pharmaceutical company Vanguard Pharmaceuticals has recently been expanding its operations into the Latin and South American Markets, with effects that could be beneficial for the distribution of a swine flu vaccine.

Top pharmaceutical sales company Vanguard Pharmaceuticals has the possibility of acquiring a sales contact for the recently developed swine flu vaccine.

With the Swine Flu Virus now a global pandemic and other top biotech companies developing a swine flu vaccine, Vanguard Pharmaceutical’s has been recruited to distribute and promote a natural alternative to these scientific solutions.

Top Biotech Company AVI BioPharma (AVII), which develops RNA-based treatments for diseases like the Ebola virus, muscular dystrophy and the influenza virus has risen in stock price recently.

The UK Department has reported significant drops in the level of swine flu cases in the UK. But with winter coming for the Northern Hemisphere, At risk groups have been reported as the first to receive swine flu vaccine.

With their best seller Quidel Influenza Test, Quidel Corp. share price has increased over 80% since April 2009. Recognized as one of the best distributors of the top pharmaceutical companies, Quidel Corp. is looking to emerge as a leading player in the early detection of one of the fastest growing epidemics, the swine flu.

With a micro-injection influenza vaccine currently in phase II of development, Sanofi Adventis has the capability to develop the first swine flu vaccine. To supply the new swine flu virus at a global scale, companies like Sanofi Aventis may join efforts with other top pharmaceutical companies like AVI Biopharma (AVII), Pure Bioscience (PURE), Roche (RHHBY) and Antigenics (AGEN).

Strategic alliances are present in businesses throughout the world. Beneficial to both parties involved, these alliances are becoming common in the healthcare industry as the global scale of the swine flu pandemic requires team work and joint efforts.